NNOX stock — Nano-X Imaging Ltd. insiders and 13F holders
NNOX
Nano-X Imaging Ltd.
NASDAQ· Healthcare· Medical Devices· CUSIP M70700105
$0.83▼ -1.52%Price as of Aug 29, 18:34 UTC · updated once a day, after the close
Key metrics
Market cap
$65.2M
P/E
—
Forward P/E
—
P/B
0.5x
Dividend yield
—
Payout
—
EPS
-$1.15
ROE
-50.12%
Profit margin
0.00%
Revenue growth
+53.10%
Beta
1.27
52-week high
$4.71
52-week low
$0.73
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
Equity, revenue and profitEquityRevenueNet income
findstockfast.com
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Revenue4 years
findstockfast.com
Net debtDebt minus cash — below zero means more cash than debt
findstockfast.com
Investors holding this
Major managers that reported this stock in their latest 13F.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
Indicator
Median
2025
2024
2023
2022
Year-end price
$2.80
$7.20
$6.37
$7.38
P/S
38.9x
15.0x
40.7x
37.2x
47.4x
P/B
1.9x
1.4x
2.4x
1.9x
1.9x
EPS
-$1.16
-$0.91
-$1.08
-$2.01
Profit margin
-594.86%
-576.13%
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligencebased solution; AI-Based Body Composition Measurement, an artificial intelligencebased body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.